OPTIMIZATION of ADVANCED MR SEQUENCES
Launched by CENTRE HOSPITALIER ST ANNE · Nov 15, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Optimization of Advanced MR Sequences," is focused on improving the quality of MRI scans, which are important imaging tests used to look at the brain for conditions like tumors, mental disorders, and strokes. The researchers want to make MRI images clearer and more reliable by using a new machine specifically designed for research in brain science.
To participate in this study, you need to be at least 18 years old, covered by social security, and for women of childbearing age, you must be using effective birth control. Participants will need to give written consent and must not have any conditions that would prevent them from undergoing an MRI, like severe claustrophobia or pregnancy. If you choose to take part, you'll help researchers gather valuable information that could lead to better MRI techniques in the future. The study is currently recruiting participants of all genders, and your involvement could make a significant difference in understanding and improving brain imaging.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 ans
- • Covered by social security
- • For women in age of procreation, under efficient contraception
- • Written consent
- Exclusion Criteria:
- • Any MR contraindication
- • Claustrophobia
- • Pregnancy
- • Under judiciary protection
About Centre Hospitalier St Anne
Centre Hospitalier St. Anne is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a strong emphasis on mental health and neurology, the center is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. By fostering collaboration among multidisciplinary teams of experienced researchers and healthcare professionals, Centre Hospitalier St. Anne aims to contribute to the development of new therapies and treatment modalities, ultimately enhancing the quality of care for patients in both local and global contexts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials